IND Swift Limited Ceftazidime Export Data — India (DGFT 2022–2026)

Name: IND Swift Limited Ceftazidime Export Records India — #15 Exporter, 7 Shipments, $149.4K FOB USD (DGFT 2022–2026)
Creator: TransData Nexus
Published: 2026-04-01T00:00:00Z
License: https://transdatanexus.com/terms-and-conditions

Suresh Sormare

Ceftazidime

India Pharmaceutical Trade Intelligence

$10.7M228 Suppliers99 CountriesHS 30042019

ExportsIndia → GHANA19.5%India → UKRAINE14.3%

ImportsITALY → India$52.7M BELGIUM → India$327.7K

IND Swift Limited — Ceftazidime Exporter #15 | $149.4K Trade Value | TransData Nexus | TransData Nexus

IND Swift Limited — Ceftazidime Exporter Profile

Indian Pharmaceutical Exporter · #15 for Ceftazidime · $149.4K export value · DGFT Verified

IND Swift Limited is the #15 Indian exporter of Ceftazidime with $149.4K in export value and 7 verified shipments. IND Swift Limited holds a 1.4% market share in Ceftazidime exports across 3 countries. The company exports 13 pharmaceutical products worth $36.7M across 9 therapeutic categories.

IND Swift Limited — Ceftazidime Export Profile: Buyers & Destinations

IND Swift Limited Ceftazidime export treemap — buyers and destination countries | TransData Nexus

Where Does India Export Ceftazidime?

Country	Value	Shipments	Share
UKRAINE	$1.0M	20	16.4%
SUDAN	$850.9K	38	13.9%
GHANA	$800.0K	16	13.1%
FRANCE	$416.6K	21	6.8%

Who Are the Top Buyers of Ceftazidime from India?

Buyer	Country	Value	Orders
ANANTA MEDICARE UKRAINE LTD.	UKRAINE	$750.0K	15
BIOMEDIC HEALTHCARE SOLUTION	MYANMAR	$200.0K	4
E P H K	HUNGARY	$174.3K	4
OA&J PHARMACEUTICALS LTD.	GHANA	$150.0K	3
ANANTA MEDICARE UKRAINE LIMITED	UKRAINE	$150.0K	3
OOO JODAS EXPOIM	RUSSIA	$143.5K	3
V P G	GERMANY	$137.7K	5
PLANETPHARMA SA	FRANCE	$129.0K	12
PRECIOUS TRUST LTD.	NIGERIA	$122.7K	5
TO THE RECEIVING DEPARTMENT	SOUTH AFRICA	$119.4K	7

India's Ceftazidime is purchased by 360 buyers worldwide. The top buyer is ANANTA MEDICARE UKRAINE LTD. (UKRAINE), followed by BIOMEDIC HEALTHCARE SOLUTION and E P H K.

How Does IND Swift Limited Compare to Nearest Ceftazidime Exporters?

Exporters ranked immediately above and below #15 by export value

#	Supplier	Export Value	Shipments	Countries	Avg/Shipment
14	GOD GIFT LABORATORY PRIVATE LIMITED	$152.5K	6	1	$25.4K
7	KILITCH DRUGS INDIA LIMITED	$150.0K	3	2	$50.0K
15	IND SWIFT LIMITED ★	$149.4K	7	3	$21.3K

IND Swift Limited ranks #15 among 228 Indian Ceftazidime exporters. Average shipment value of $21.3K compared to the market average of $19.4K. The closest competitors by value are GOD GIFT LABORATORY PRIVATE LIMITED and KILITCH DRUGS INDIA LIMITED.

Which Indian Ports Ship Ceftazidime Exports?

Port	Shipments	% Share
SAHAR AIR	118	12.8%
SAHAR AIR CARGO ACC (INBOM4)	102	11.1%
NHAVA SHEVA SEA (INNSA1)	88	9.6%
DELHI AIR	72	7.8%
DELHI AIR CARGO ACC (INDEL4)	62	6.7%
JNPT/ NHAVA SHEVA SEA	36	3.9%
Bombay Air	35	3.8%
BANGALORE ACC (INBLR4)	31	3.4%

Geopolitical & Trade Policy Impact on IND Swift Limited's Ceftazidime Exports

Ind-Swift Laboratories' export operations have been influenced by recent geopolitical developments. The Israel-Iran conflict has heightened security risks in the Strait of Hormuz and the Red Sea–Suez Canal corridor, prompting major carriers to reroute shipments around the Cape of Good Hope. This detour has extended transit times by 10–20 days and increased freight rates by 40–50% on key India–Europe routes, impacting the company's logistics and cost structures. (livemint.com)

Conversely, the India–European Union Free Trade Agreement (India–EU FTA), concluded in January 2026, is poised to benefit Indian pharmaceutical exporters. The agreement eliminates tariffs on most European pharmaceutical imports, enhancing the competitiveness of Indian products in the EU market. This development presents an opportunity for Ind-Swift Laboratories to expand its footprint in Europe. (en.wikipedia.org)

In the United States, the reshoring of pharmaceutical manufacturing and potential imposition of tariffs on imports pose challenges for Indian exporters. While there are currently no import duties on Indian pharmaceutical products entering the US, the introduction of tariffs could affect the profitability of low-margin generic drugs, potentially leading to market exits. (cfo.economictimes.indiatimes.com)

IND Swift Limited — Regulatory Compliance & Quality Standards

Compliance with international regulatory standards remains paramount for Indian pharmaceutical exporters. Ind-Swift Laboratories has demonstrated a commitment to quality by adhering to Good Manufacturing Practices (GMP) as stipulated by the US FDA, WHO, and EU authorities. The company's manufacturing facilities in Punjab and Jammu have been inspected and approved by these regulatory bodies, facilitating access to regulated markets.

The evolving regulatory landscape, including the EU's Falsified Medicines Directive, necessitates continuous investment in quality systems and supply chain transparency. Ind-Swift Laboratories' focus on high-margin formulations underscores the importance of maintaining stringent quality standards to meet global regulatory requirements and sustain market access.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Product Matching: Ceftazidime shipments identified using fuzzy matching on DGFT product description fields, validated against Indian Pharmacopoeia nomenclature.
2.Supplier Identification: IND Swift Limited matched across shipments using name normalization, accounting for company name formatting variations.
3.Statistical Normalization: Shipment values are statistically normalized to ensure accurate market share representation. This removes the impact of unusually large one-off transactions that could distort company rankings.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

Global Coverage

Exports to 99+ countries, 360+ buyers

Expert-Reviewed

Analyzed by pharmaceutical trade specialists

Ceftazidime

Ceftazidime

IND Swift Limited — Ceftazidime Exporter Profile

IND Swift Limited — Ceftazidime Export Profile: Buyers & Destinations

Where Does India Export Ceftazidime?

Who Are the Top Buyers of Ceftazidime from India?

What Is India's Total Ceftazidime Export Value and How Much Does IND Swift Limited Contribute?

What Is the Average Shipment Value for IND Swift Limited's Ceftazidime Exports?

How Does IND Swift Limited Compare to Other Indian Ceftazidime Exporters?

How Does IND Swift Limited Compare to Nearest Ceftazidime Exporters?

Which Indian Ports Ship Ceftazidime Exports?

What Other Advanced Antibiotics Products Does IND Swift Limited Export?

Geopolitical & Trade Policy Impact on IND Swift Limited's Ceftazidime Exports

IND Swift Limited — Regulatory Compliance & Quality Standards

About IND Swift Limited

Market Intelligence

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

Analysis Methodology

Get Ceftazidime Export Data from IND Swift Limited

Ceftazidime Stats

Company Overview

Top Products by IND Swift Limited

Related Analysis

Need Detailed Export Data?

Data Source